Mr Christophe Lorieux France

Our software enables a rapid development of web or mobile portals or "app stores", dedicated to help people to manage their health or autonomy.

Technically, we facilitate interaction between services, serious games, algorithms and medical contents that will be integrated in a single portal where they will have a single management tool and one single database.

In addition, an administration tool enables to its operator the management of the platform : CMS, enrollment, statistics and connectors.

To date, we expect 1 M€ turnover in 2015, with 6 customers, mainly insurers and state organization like CNAM, the equivalent of NHS, the Regional Health Agency (ARS Ile de France) or City of Paris.

For instance, we have developed an e-health portal for employees. This portal, called "MyPrevention", integrates 12 inter-connected applications : e-health prevention applications, an encyclopedia, information and coaching platforms, ...

The services are provided by 12 different companies.

About this project, our lauching plan, forecasts 50 000 users by the end of October 2015 and 400.000 in 2016.

We have also developped a social network which integrates a serious game, an agenda, a visio conference access, a connection with a services platform.

This project has been designed for the dependant persons of the city of Paris and will be launched and operated by the Welfare Department of the City of Paris.

Even if the French market is still under creation, we strongly believe that market shares must be grabbed now. So far, we have a successful commercial activity and we are strongly confident that we will be in a strong position to address a mass e-health market. 

This market will be driven by the demand expressed by end users who expect more collaboration between insurers, national healthcare operators , pharmaceutical labs,  in order to provide them with integrated care services.

Our strategy is always the same :

- identifying the main actors on a market

- finalizing partnership in order to adress the market behind his brand and his expertise.

SANTECH
LinkedIn logo CEO 

Professor Didier Loulmet United States

NYU Langone Medical Center is one of the nation’s premier academic medical centers. Our trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.

Located in the heart of Manhattan, with additional facilities throughout the New York City area, NYU Langone consists of four hospitals:

NYU Langone Medical Center
Director, Robotic Cardiac Surgery, Tisch Hospital - Chief Cardiac Surgery at NYULMC 

Ms Ellen Lubman United States

Leading Growth Pharma

Allergan is a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma.  The company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth.

Brand Portfolio

The Allergan Brand portfolio features six blockbuster franchises in key therapeutic categories, including

  • Dermatology and Aesthetics
  • CNS
  • Eye Care
  • Women’s Health and Urology
  • GI and Cystic Fibrosis 
  • Cardiovascular and Infectious Disease

Supporting these blockbuster franchises is the company’s industry-leading U.S. sales force with extraordinary marketing reach and increased relevance with primary care physicians and specialists.

Allergan
Vice President